Document is current
Any future updates will be listed below
-
Authors
Dalbeni, Andrea
Cattazzo, Filippo
Vicardi, Marco
Franceschini, Eugenio
Campani, Claudia
Cabibbo, Giuseppe
Vivaldi, Caterina
Palloni, Andrea
Pressiani, Tiziana
Iavarone, Massimo
Auriemma, Alessandra
Natola, Leonardo A.
Federico, Piera
Ponziani, Francesca Romana
Svegliati-Baroni, Gianluca
Stefanini, Benedetta
Soldà, Caterina
Foschi, Francesco Giuseppe
De Lorenzo, Stefania
Garajova, Ingrid
Marra, Fabio
Celsa, Ciro
Masi, Gianluca
Brandi, Giovanni
Rimassa, Lorenza
Bruccoleri, Mariangela
Daniele, Bruno
Stella, Leonardo
Ricci, Maria
Sacerdoti, David
Tovoli, Francesco
,
Ravaioli, Federico
Boe, Maria
Ascari, Sara
Perna, Anna
Bellucco, Maria Elena
Scorzoni, Chiara
Scandali, Giulia
Pellegrini, Elisa
- License Information
-
More Information
Article History
Received: 4 April 2025
Accepted: 24 October 2025
First Online: 23 November 2025
Declarations
:
: Giuseppe Cabibbo has served on in advisory board and received speaker fees for Bayer, Eisai, Ipsen, and AstraZeneca, MSD, Roche, Gilead. Ciro Celsa received speaker fees for AstraZeneca, EISAI, MSD, Ipsen, and received grants from Roche. Andrea Dalbeni is a consultant for Roche, Astrazeneca, Eisai, MSD. Support for congress attendance from Roche, Astrazeneca, Eisai, MSD. Massimo Iavarone in advisory board and received speaker fees for Gilead Sciences, Bayer, AstraZeneca, Roche, Roche Diagnostics, EISAI, IPSEN, MSD. Tiziana Pressiani received/reports consulting fees from Bayer, Ipsen and Astra Zeneca; institutional research funding from Roche, Bayer, Astra Zeneca.; support for congress attendance from Roche. Lorenza Rimassa reports receiving grant / research funding from AbbVie, Agios, AstraZeneca, BeiGene, Eisai, Eli Lilly, Exelixis, Fibrogen, Incyte, IPSEN, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences and Zymeworks. Consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, Bristol Myers Squibb, Eisai, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, IPSEN, IQVIA, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology and Zymeworks. Lecture fees from AstraZeneca, Bayer, Bristol Myers Squibb, Guerbet, Incyte, IPSEN, Roche and Servier. Travel expenses from Astra Zeneca. Francesca Romana Ponziani received speaker fees, advisory board fees and travel grants from Bayer, MSD, Roche, Eisai, Ipsen, Astra-Zeneca, Gilead, Abbvie. Caterina Soldà reports consulting/advisory role for MSD and EISAI; speakers’ bureau for Roche and MSD. Francesco Tovoli is a consultant for Roche, Astrazeneca, Eisai. Caterina Vivaldi CV reports consulting or advisory role for Amgen, AstraZeneca, BMS, EISAI, Incyte, MSD, Roche, Servier, Taiho Oncology. All the other authors do not report any competing interests.
